Literature DB >> 3756829

Diagnostic value of upper intestinal fiber endoscopy in primary small intestinal lymphoma. A prospective study by the Tunisian-French Intestinal Lymphoma Group.

M Halphen, T Najjar, H Jaafoura, M Cammoun, G Tufrali.   

Abstract

To assess the diagnostic value of upper intestinal fiber endoscopy in primary small intestinal lymphomas observed in an underdeveloped Mediterranean country, the endoscopic records of 40 patients (Group A) offering histologic evidence of lymphoma were compared with those of 80 patients (Group B) displaying clinical findings of small intestinal disease, but who eventually proved to be free of lymphoma after a complete work-up. The endoscopic procedure reached the jejunum in 91% cases and was well tolerated with only one reversible complication. Five primary endoscopic patterns could be defined, occurring either alone or in various combinations. The infiltrated pattern was the most sensitive (0.80) and specific (0.96) finding with predictive positive and negative values reaching 0.88 and 0.93, followed by the nodular pattern (sensitivity 0.60, specificity 0.84). Other primary lesions (ulcerations, mosaic pattern, mucosal fold thickening alone) were either nonsensitive or nonspecific or both. The infiltrated pattern proved to be more valuable than any association of primary lesion. Per endoscopic biopsies were diagnostic of lymphoma in 85% cases. These findings strongly suggest that upper intestinal fiber endoscopy, using long ending view instruments should be the first investigation in patients suspected of small intestinal lymphoma in developing Mediterranean countries.

Entities:  

Mesh:

Year:  1986        PMID: 3756829     DOI: 10.1002/1097-0142(19861101)58:9<2140::aid-cncr2820580930>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and "Mediterranean" lymphomas.

Authors:  J C Rambaud; M Halphen; A Galian; A Tsapis
Journal:  Springer Semin Immunopathol       Date:  1990

2.  The value of double-contrast study of the small intestine in immunoproliferative small intestinal disease.

Authors:  T Matsumoto; M Iida; T Matsui; H Tanaka; M Fujishima
Journal:  Gastrointest Radiol       Date:  1990

Review 3.  Heavy Chain Disease of the Small Bowel.

Authors:  Giada Bianchi; Aliyah R Sohani
Journal:  Curr Gastroenterol Rep       Date:  2018-01-25

Review 4.  Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up.

Authors:  Calogero Vetro; Alessandra Romano; Irene Amico; Concetta Conticello; Giovanna Motta; Amalia Figuera; Annalisa Chiarenza; Cosimo Di Raimondo; Giorgio Giulietti; Giacomo Bonanno; Giuseppe Alberto Palumbo; Francesco Di Raimondo
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Diagnostic value of push-type jejunal endoscopy in primary jejunal carcinoma.

Authors:  S Nakamura; M Iida; Y Nakao; T Matsui; T Yao; M Fujishima
Journal:  Surg Endosc       Date:  1993 May-Jun       Impact factor: 4.584

Review 6.  Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.

Authors:  Roberto Ria; Franco Dammacco; Angelo Vacca
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

7.  Mucosa-associated lymphoid tissue lymphoma in the terminal ileum: A case report.

Authors:  Vitor Lauar Pimenta de Figueiredo; Igor Braga Ribeiro; Diogo Turiani Hourneaux de Moura; Cristiano Claudino Oliveira; Eduardo Guimarães Hourneaux de Moura
Journal:  World J Gastrointest Endosc       Date:  2022-03-16

8.  Immunoproliferative Small Intestinal Disease Diagnosed by Double-balloon Endoscopy with Biopsy Sampling.

Authors:  Miguel Ricardo Rodríguez Meza; Masanao Nakamura; Takeshi Yamamura; Keiko Maeda; Tsunaki Sawada; Eri Ishikawa; Naomi Kakushima; Kazuhiro Furukawa; Eizaburo Ohno; Takashi Honda; Hiroki Kawashima; Masatoshi Ishigami
Journal:  Intern Med       Date:  2022-02-08       Impact factor: 1.282

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.